2UF-61095-05000
4 vaccinations
2 coded responses
44 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 850 / AZ
- Registered
- 2021-02-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-05
Registered in v-safe
-
2021-02-05
Dose 1 — Moderna
- 2021-02-05
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
-
2021-03-12
Dose 2 — Moderna
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, NauseaAdult check-in
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-06-11
- 2021-09-12
-
2021-12-29
Dose 3 — Pfizer-BioNTech
-
2022-01-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-01-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-03
- 2022-01-05
- 2022-01-12
-
2022-01-19
Survey response — day 21, dose 3MedDRA: Cough, Headache, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Bad headache, cough, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-01-26
- 2022-02-04
- 2022-02-09
- 2022-04-01
- 2022-06-29
-
2022-09-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-04
- 2022-11-09
-
2022-12-28
Survey response — 3 months, dose 4MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-05 | Moderna | |
| 2 | 2021-03-12 | Moderna | |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 21, dose 3
Symptoms: Bad headache, cough, runny nose
Release 12 — 3 months, dose 4
Symptoms: Headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release